{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:48:00Z","timestamp":1794084480424,"version":"4.8.0"},"reference-count":71,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T00:00:00Z","timestamp":1762387200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Neoadjuvant treatment has demonstrated clinical benefits in advanced gallbladder cancer (GBC). However, the overall response rate remains suboptimal, and the underlying mechanisms driving treatment efficacy are not fully understood.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>This study aimed to evaluate the therapeutic effects of neoadjuvant chemo-immunotherapy (NAT) combining gemcitabine, nab-paclitaxel, and anti-PD-1 immunotherapy in advanced GBC, and to investigate the associated tumor microenvironment (TME) alterations. Single-cell RNA sequencing and multiplex immunohistochemistry were utilized to analyze the cellular composition of the TME in patients who successfully underwent downstaging.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      NAT significantly reshaped the tumor-immune landscape, characterized by an expansion of follicular helper T (Tfh) cells and the formation of tertiary lymphoid structures (TLSs) in 50% of treated tumors. Inflammatory cancer-associated fibroblasts (CAFs) increased and exhibited upregulation of\n                      <jats:italic toggle=\"yes\">CCL19<\/jats:italic>\n                      and\n                      <jats:italic toggle=\"yes\">CXCL12<\/jats:italic>\n                      , potentially promoting Tfh cell recruitment and TLS formation. Additionally, NAT led to an expansion of GZMB\n                      <jats:sup>+<\/jats:sup>\n                      cytotoxic CD8\n                      <jats:sup>+<\/jats:sup>\n                      T cells with an exhausted phenotype in GBC, but not in adjacent normal tissues. The treatment also increased the number and effector functions of natural killer cells while reducing tumor-promoting macrophages and angiogenesis-related CAFs. Furthermore, NAT decreased the cancer stem cell-like subpopulation while increasing a cancer cell subset with enhanced antigen-presenting capacity.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study suggested the potential efficacy of NAT in advanced GBC and revealed alterations in the TME following treatment. The findings provided insights into the mechanisms underlying NAT responses and offered valuable directions for optimizing therapeutic strategies in GBC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/js9.0000000000003883","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T23:00:14Z","timestamp":1762556414000},"page":"4110-4124","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Single-cell profiling unveils the immuno-favorable tumor microenvironment remodeling after successful neoadjuvant therapy for advanced gallbladder cancer"],"prefix":"10.1097","volume":"112","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9459-4433","authenticated-orcid":false,"given":"Qiu-Yi","family":"Tang","sequence":"first","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-You","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian-Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Immunology & Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ling","family":"Song","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Di","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Yi","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Wei","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Kai","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Ting","family":"Dai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-Xin","family":"Huang","sequence":"additional","affiliation":[{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Institute of Immunology & Department of Immunology and Microbiology, Key Laboratory of Cell Differentiation and Apoptosis of Chinese Ministry of Education, Faculty of Basic Medicine, Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang-Song","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Gong","sequence":"additional","affiliation":[{"name":"Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China"},{"name":"Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai, China"},{"name":"Shanghai Research Center of Biliary Tract Disease, Shanghai, China"},{"name":"Biliary Disease Research Institute of Shanghai Jiao Tong University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11,6]]},"reference":[{"key":"R1-20260512","doi-asserted-by":"crossref","first-page":"2402072","DOI":"10.1080\/07853890.2024.2402072","article-title":"What eliminates the chance for cure: a multi-center evaluation on 10-year follow-up of gallbladder cancer after surgical resection","volume":"56","author":"Ma","year":"2024","journal-title":"Ann Med"},{"key":"R2-20260512","doi-asserted-by":"crossref","first-page":"427\u201337","DOI":"10.1016\/j.cgh.2017.08.017","article-title":"Worldwide burden of and trends in mortality from gallbladder and other biliary tract cancers","volume":"16","author":"Torre","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R3-20260512","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41572-022-00398-y","article-title":"Gallbladder cancer","volume":"8","author":"Roa","year":"2022","journal-title":"Nat Rev Dis Primer"},{"key":"R4-20260512","doi-asserted-by":"crossref","first-page":"444\u201359","DOI":"10.21037\/hbsn-22-597","article-title":"Laparoscopic versus open surgery in treating patients with gallbladder cancer: a systematic review and meta-analysis","volume":"13","author":"Li","year":"2024","journal-title":"Hepatobiliary Surg Nutr"},{"key":"R5-20260512","doi-asserted-by":"crossref","first-page":"3739\u201342","DOI":"10.3748\/wjg.v30.i32.3739","article-title":"Radical cholecystectomy without liver resection for peritoneal side early incidental gallbladder cancer","volume":"30","author":"Piccolo","year":"2024","journal-title":"World J Gastroenterol"},{"key":"R6-20260512","doi-asserted-by":"crossref","first-page":"106234","DOI":"10.1016\/j.ijsu.2022.106234","article-title":"Current management of incidental gallbladder cancer: a review","volume":"98","author":"Feo","year":"2022","journal-title":"Int J Surg Lond Engl"},{"key":"R7-20260512","first-page":"365\u201368","article-title":"A case of advanced gallbladder cancer responding to neoadjuvant intra-arterial chemotherapy","volume":"26","author":"Kawabata","year":"1999","journal-title":"Gan To Kagaku Ryoho"},{"key":"R8-20260512","doi-asserted-by":"crossref","first-page":"906\u201316","DOI":"10.1016\/j.jamcollsurg.2016.12.058","article-title":"Systemic chemotherapy combined with resection for locally advanced gallbladder carcinoma: surgical and survival outcomes","volume":"224","author":"Creasy","year":"2017","journal-title":"J Am Coll Surg"},{"key":"R9-20260512","doi-asserted-by":"crossref","first-page":"841\u201347","DOI":"10.1016\/j.hpb.2018.03.008","article-title":"Outcome of neoadjuvant chemotherapy in \u2018locally advanced\/borderline resectable\u2019 gallbladder cancer: the need to define indications","volume":"20","author":"Chaudhari","year":"2018","journal-title":"Hpb"},{"key":"R10-20260512","first-page":"679\u201386","article-title":"Pathologic and prognostic implications of incidental versus nonincidental gallbladder cancer: a 10-institution study from the United States extrahepatic biliary malignancy consortium","volume":"83","author":"Ethun","year":"2017","journal-title":"Am Surg"},{"key":"R11-20260512","doi-asserted-by":"crossref","first-page":"209\u201315","DOI":"10.1007\/s00280-017-3353-2","article-title":"Prognostic factors in patients with advanced biliary tract cancer treated with first-line gemcitabine plus cisplatin: retrospective analysis of 740 patients","volume":"80","author":"Kim","year":"2017","journal-title":"Cancer Chemother Pharmacol"},{"key":"R12-20260512","doi-asserted-by":"crossref","first-page":"372\u201379","DOI":"10.1002\/jso.24837","article-title":"Emerging role of multimodality treatment in gall bladder cancer: outcomes following 510 consecutive resections in a tertiary referral center","volume":"117","author":"Patkar","year":"2018","journal-title":"J Surg Oncol"},{"key":"R13-20260512","first-page":"2568\u201376","article-title":"Comparison of safety, efficacy, and patient satisfaction with thermal ablation versus endoscopic thyroidectomy for benign thyroid nodules in a propensity-matched cohort","volume":"110","author":"Kuo","year":"2024","journal-title":"Int J Surg Lond Engl"},{"key":"R14-20260512","doi-asserted-by":"crossref","first-page":"87\u201394","DOI":"10.5005\/jp-journals-10018-1348","article-title":"Neoadjuvant chemotherapy for advanced gallbladder cancer: do we have enough evidence? a systematic review","volume":"11","author":"Naveed","year":"2021","journal-title":"Euroasian J Hepato-Gastroenterol"},{"key":"R15-20260512","first-page":"1","article-title":"Prognostic impact of neoadjuvant chemotherapy in localized or locoregionally advanced gallbladder cancer: a population-based and propensity score matched SEER analysis","author":"Xiong","year":"2024","journal-title":"Cancer Control [Internet]"},{"key":"R16-20260512","doi-asserted-by":"crossref","first-page":"43","DOI":"10.21037\/cco.2019.07.05","article-title":"Systemic therapy of gallbladder cancer: review of first line, maintenance, neoadjuvant and second line therapy specific to gallbladder cancer","volume":"8","author":"Azizi","year":"2019","journal-title":"Chin Clin Oncol"},{"key":"R17-20260512","doi-asserted-by":"crossref","first-page":"181\u201388","DOI":"10.1016\/S1470-2045(11)70301-1","article-title":"Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study","volume":"13","author":"Lee","year":"2012","journal-title":"Lancet Oncol"},{"key":"R18-20260512","doi-asserted-by":"crossref","first-page":"385\u201388","DOI":"10.1093\/jjco\/hyv213","article-title":"Randomized Phase III study of gemcitabine plus S-1 versus gemcitabine plus cisplatin in advanced biliary tract cancer: Japan clinical oncology group study (JCOG1113, FUGA-BT)","volume":"46","author":"Mizusawa","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"R19-20260512","doi-asserted-by":"crossref","first-page":"57\u201362","DOI":"10.1093\/jjco\/hyv148","article-title":"FOLFOX-4 as second-line therapy after failure of gemcitabine and platinum combination in advanced gall bladder cancer patients","volume":"46","author":"Dodagoudar","year":"2016","journal-title":"Jpn J Clin Oncol"},{"key":"R20-20260512","doi-asserted-by":"crossref","first-page":"977963","DOI":"10.3389\/fonc.2022.977963","article-title":"Successful conversion surgery for locally advanced gallbladder cancer after gemcitabine and nab-paclitaxel chemotherapy","volume":"12","author":"Yang","year":"2022","journal-title":"Front Oncol"},{"key":"R21-20260512","doi-asserted-by":"crossref","first-page":"694\u2013704","DOI":"10.1016\/S2468-1253(24)00095-5","article-title":"Durvalumab or placebo plus gemcitabine and cisplatin in participants with advanced biliary tract cancer (TOPAZ-1): updated overall survival from a randomised phase 3 study","volume":"9","author":"Oh","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R22-20260512","doi-asserted-by":"crossref","first-page":"626\u201335","DOI":"10.1016\/S1470-2045(24)00082-2","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer (TOPAZ-1): patient-reported outcomes from a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"25","author":"Burris","year":"2024","journal-title":"Lancet Oncol"},{"key":"R23-20260512","first-page":"1853\u201365","article-title":"Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"401","author":"Kelley","year":"2023","journal-title":"Lancet Lond Engl"},{"key":"R24-20260512","article-title":"Revised strengthening the reporting of cohort, cross-sectional and case-control studies in surgery (STROCSS) guideline: an update for the age of artificial intelligence","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R25-20260512","doi-asserted-by":"crossref","first-page":"228\u201347","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"R26-20260512","doi-asserted-by":"crossref","first-page":"1128\u201341","DOI":"10.1016\/j.jhep.2021.06.023","article-title":"Single-cell RNA-sequencing atlas reveals an MDK-dependent immunosuppressive environment in ErbB pathway-mutated gallbladder cancer","volume":"75","author":"Zhang","year":"2021","journal-title":"J Hepatol"},{"key":"R27-20260512","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","article-title":"Integrated analysis of multimodal single-cell data","volume":"184","author":"Hao","year":"2021","journal-title":"Cell"},{"key":"R28-20260512","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13059-020-1950-6","article-title":"Decontamination of ambient RNA in single-cell RNA-seq with DecontX","volume":"21","author":"Yang","year":"2020","journal-title":"Genome Biol"},{"key":"R29-20260512","doi-asserted-by":"crossref","first-page":"abe6474","DOI":"10.1126\/science.abe6474","article-title":"Pan-cancer single-cell landscape of tumor-infiltrating T cells","volume":"374","author":"Zheng","year":"2021","journal-title":"Science"},{"key":"R30-20260512","doi-asserted-by":"crossref","first-page":"30\u201334","DOI":"10.1038\/s41587-020-0605-1","article-title":"Cell type prioritization in single-cell data","volume":"39","author":"Skinnider","year":"2021","journal-title":"Nat Biotechnol"},{"key":"R31-20260512","doi-asserted-by":"crossref","first-page":"eabf9419","DOI":"10.1126\/science.abf9419","article-title":"Tertiary lymphoid structures in cancer","volume":"375","author":"Schumacher","year":"2022","journal-title":"Science"},{"key":"R32-20260512","doi-asserted-by":"crossref","first-page":"608\u201318","DOI":"10.1016\/j.jhep.2021.10.030","article-title":"Distribution and density of tertiary lymphoid structures predict clinical outcome in intrahepatic cholangiocarcinoma","volume":"76","author":"Ding","year":"2022","journal-title":"J Hepatol"},{"key":"R33-20260512","doi-asserted-by":"crossref","first-page":"e006425","DOI":"10.1136\/jitc-2022-006425","article-title":"Localization and density of tertiary lymphoid structures associate with molecular subtype and clinical outcome in colorectal cancer liver metastases","volume":"11","author":"Zhang","year":"2023","journal-title":"J Immunother Cancer"},{"key":"R34-20260512","doi-asserted-by":"crossref","first-page":"e20221220","DOI":"10.1084\/jem.20221220","article-title":"Protective fibroblastic niches in secondary lymphoid organs","volume":"221","author":"De Martin","year":"2023","journal-title":"J Exp Med"},{"key":"R35-20260512","doi-asserted-by":"crossref","first-page":"369\u201380","DOI":"10.1038\/s41590-020-0635-3","article-title":"Lymph node stromal cells: cartographers of the immune system","volume":"21","author":"Krishnamurty","year":"2020","journal-title":"Nat Immunol"},{"key":"R36-20260512","first-page":"430","article-title":"Fibroblastic reticular cells generate protective intratumoral T cell environments in lung cancer","author":"Onder","year":"2024","journal-title":"Cell"},{"key":"R37-20260512","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ccell.2021.04.004","article-title":"Single-cell dissection of cellular components and interactions shaping the tumor immune phenotypes in ovarian cancer","volume":"39","author":"Hornburg","year":"2021","journal-title":"Cancer Cell"},{"key":"R38-20260512","doi-asserted-by":"crossref","first-page":"1308\u201320","DOI":"10.1158\/0008-5472.CAN-17-1987","article-title":"Germinal centers determine the prognostic relevance of tertiary lymphoid structures and are impaired by corticosteroids in lung squamous cell carcinoma","volume":"78","author":"Sili\u0146a","year":"2018","journal-title":"Cancer Res"},{"key":"R39-20260512","doi-asserted-by":"crossref","first-page":"129\u201333","DOI":"10.1016\/S0014-5793(97)01503-2","article-title":"Isolation and characterization of the circulating form of human endostatin","volume":"420","author":"St\u00e4ndker","year":"1997","journal-title":"FEBS Lett"},{"key":"R40-20260512","doi-asserted-by":"crossref","first-page":"2730\u201335","DOI":"10.1101\/gad.308904","article-title":"Notch3 is required for arterial identity and maturation of vascular smooth muscle cells","volume":"18","author":"Domenga","year":"2004","journal-title":"Genes Dev"},{"key":"R41-20260512","doi-asserted-by":"crossref","first-page":"101009","DOI":"10.1016\/j.neo.2024.101009","article-title":"Unveiling the role of AGT in lipid metabolism and regulated cell death in colon cancer","volume":"54","author":"Wu","year":"2024","journal-title":"Neoplasia N Y N"},{"key":"R42-20260512","doi-asserted-by":"crossref","first-page":"108225","DOI":"10.1016\/j.intimp.2021.108225","article-title":"AGT serves as a potential biomarker and drives tumor progression in colorectal carcinoma","volume":"101","author":"Chen","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"R43-20260512","doi-asserted-by":"crossref","first-page":"9112\u201315","DOI":"10.1158\/0008-5472.CAN-08-0851","article-title":"Does the renin-angiotensin system participate in regulation of human vasculogenesis and angiogenesis?","volume":"68","author":"Khakoo","year":"2008","journal-title":"Cancer Res"},{"key":"R44-20260512","doi-asserted-by":"crossref","first-page":"385\u201399","DOI":"10.2174\/1570161043385556","article-title":"cell proliferation and angiogenesis regulator: biologic and therapeutic implications in cancer","volume":"2","author":"Escobar","year":"2004","journal-title":"Curr Vasc Pharmacol"},{"key":"R45-20260512","first-page":"715","article-title":"Angiotensin-(1-7) can promote cell migration and tumor growth of clear cell renal cell carcinoma","volume":"73","author":"Sobczuk","year":"2022","journal-title":"J Physiol Pharmacol Off J Pol Physiol Soc"},{"key":"R46-20260512","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ejphar.2021.174415","article-title":"Angiotensin II promotes primary tumor growth and metastasis formation of murine TNBC 4T1 cells through the fibroblasts around cancer cells","volume":"909","author":"Takiguchi","year":"2021","journal-title":"Eur J Pharmacol"},{"key":"R47-20260512","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/s41467-021-21043-4","article-title":"Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution","volume":"12","author":"Liu","year":"2021","journal-title":"Nat Commun"},{"key":"R48-20260512","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13073-023-01164-9","article-title":"Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing","volume":"15","author":"Hu","year":"2023","journal-title":"Genome Med"},{"key":"R49-20260512","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41392-022-01130-8","article-title":"The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing","volume":"7","author":"Wang","year":"2022","journal-title":"Signal Transduct Target Ther"},{"key":"R50-20260512","doi-asserted-by":"crossref","first-page":"1476\u201390","DOI":"10.1158\/2326-6066.CIR-21-0030","article-title":"CD137 costimulation counteracts TGF\u03b2 inhibition of NK-cell antitumor function","volume":"9","author":"Cabo","year":"2021","journal-title":"Cancer Immunol Res"},{"key":"R51-20260512","doi-asserted-by":"crossref","first-page":"eadg1487","DOI":"10.1126\/sciimmunol.adg1487","article-title":"Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response","volume":"8","author":"Dykema","year":"2023","journal-title":"Sci Immunol"},{"key":"R52-20260512","first-page":"543\u201353","article-title":"Heterogeneity of tumor-infiltrating myeloid cells in era of single-cell genomics","volume":"34","author":"Chu","year":"2022","journal-title":"Chin J Cancer Res Chung-Kuo Yen Cheng Yen Chiu"},{"key":"R53-20260512","doi-asserted-by":"crossref","first-page":"eadh9069","DOI":"10.1126\/sciadv.adh9069","article-title":"Comprehensive single-cell analysis demonstrates radiotherapy-induced infiltration of macrophages expressing immunosuppressive genes into tumor in esophageal squamous cell carcinoma","volume":"9","author":"Oyoshi","journal-title":"Sci Adv"},{"key":"R54-20260512","doi-asserted-by":"crossref","first-page":"5284\u201395","DOI":"10.1158\/0008-5472.CAN-21-0101","article-title":"Characterizing macrophage diversity in metastasis-bearing lungs reveals a lipid-associated macrophage subset","volume":"81","author":"Huggins","year":"2021","journal-title":"Cancer Res"},{"key":"R55-20260512","doi-asserted-by":"crossref","first-page":"900\u201316","DOI":"10.1158\/2326-6066.CIR-21-0568","article-title":"Hematopoietic prostaglandin D2 synthase controls tfh\/th2 communication and limits Tfh antitumor effects","volume":"10","author":"Mary","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"R56-20260512","first-page":"949\u201365","article-title":"Prostaglandin pathways: opportunities for cancer prevention and therapy","volume":"82","author":"Wang","year":"2022","journal-title":"Cancer Res"},{"key":"R57-20260512","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.cell.2020.03.048","article-title":"Single-cell analyses inform mechanisms of myeloid-targeted therapies in colon cancer","volume":"181","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"R58-20260512","doi-asserted-by":"crossref","first-page":"2021):583\u2013609","DOI":"10.1146\/annurev-immunol-110519-071134","article-title":"Insights gained from single-cell analysis of immune cells in the tumor microenvironment","volume":"39","author":"Ren","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"R59-20260512","doi-asserted-by":"crossref","first-page":"1976\u201388","DOI":"10.1038\/s12276-020-00538-y","article-title":"Tumor-promoting macrophages prevail in malignant ascites of advanced gastric cancer","volume":"52","author":"Eum","year":"2020","journal-title":"Exp Mol Med"},{"key":"R60-20260512","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","article-title":"Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"R61-20260512","doi-asserted-by":"crossref","first-page":"826\u201328","DOI":"10.21037\/jtd-23-1771","article-title":"Unraveling the intricacies of neoadjuvant immune checkpoint blockade in esophageal squamous cell carcinoma: a comprehensive single-cell perspective","volume":"16","author":"Zou","year":"2024","journal-title":"J Thorac Dis"},{"key":"R62-20260512","doi-asserted-by":"crossref","first-page":"EVIDoa220001","DOI":"10.1056\/EVIDoa2200015","article-title":"Durvalumab plus gemcitabine and cisplatin in advanced biliary tract cancer","volume":"1","author":"Oh","year":"2022","journal-title":"NEJM Evid"},{"key":"R63-20260512","first-page":"86","article-title":"PD-1 blockade increases the self-renewal of stem-like CD8 T cells to compensate for their accelerated differentiation into effectors","volume":"8","author":"Gill","journal-title":"Sci Immunol"},{"key":"R64-20260512","doi-asserted-by":"crossref","first-page":"e2221985120","DOI":"10.1073\/pnas.2221985120","article-title":"Characteristics and anatomic location of PD-1+TCF1+ stem-like CD8 T cells in chronic viral infection and cancer","volume":"120","author":"Im","journal-title":"Proc Natl Acad Sci USA"},{"key":"R65-20260512","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat Commun"},{"key":"R66-20260512","doi-asserted-by":"crossref","first-page":"e1261779","DOI":"10.1080\/2162402X.2016.1261779","article-title":"Adaptive resistance to anti-PD1 therapy by Tim-3 upregulation is mediated by the PI3K-Akt pathway in head and neck cancer","volume":"6","author":"Shayan","year":"2017","journal-title":"Oncoimmunology"},{"key":"R67-20260512","doi-asserted-by":"crossref","first-page":"e000957","DOI":"10.1136\/jitc-2020-000957","article-title":"TIGIT in cancer immunotherapy","volume":"8","author":"Chauvin","year":"2020","journal-title":"J Immunother Cancer"},{"key":"R68-20260512","doi-asserted-by":"crossref","first-page":"1089\u2013111","DOI":"10.1007\/s11864-024-01243-y","article-title":"Recent advances in immunotherapy for advanced biliary tract cancer","volume":"25","author":"Yue","year":"2024","journal-title":"Curr Treat Options Oncol"},{"key":"R69-20260512","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/s41467-018-04313-6","article-title":"STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion","volume":"9","author":"Hsu","year":"2018","journal-title":"Nat Commun"},{"key":"R70-20260512","doi-asserted-by":"crossref","first-page":"217432","DOI":"10.1016\/j.canlet.2024.217432","article-title":"Mechanisms of low MHC I expression and strategies for targeting MHC I with small molecules in cancer immunotherapy","volume":"611","author":"Kong","year":"2025","journal-title":"Cancer Lett"},{"key":"R71-20260512","doi-asserted-by":"crossref","first-page":"2470\u201382","DOI":"10.3748\/wjg.v23.i14.2470","article-title":"Biliary tract cancer stem cells - translational options and challenges","volume":"23","author":"Mayr","year":"2017","journal-title":"World J Gastroenterol"}],"container-title":["International Journal of Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003883","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:17:05Z","timestamp":1778581025000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/JS9.0000000000003883"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,6]]},"references-count":71,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/js9.0000000000003883","relation":{},"ISSN":["1743-9159"],"issn-type":[{"value":"1743-9159","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,6]]},"assertion":[{"value":"2025-07-07","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}